Abstract
The Millennium Declaration committed the 193 member states of the United Nations to end poverty by 2015. Despite the efforts of the UN and World Health Organisation, and the G8 commitment to spend a fixed proportion of gross national income on overseas aid, more than 2.6 billion people still lack access to proper sanitation. The absence of effective public health strategies in developing countries results in significant health burdens following gastrointestinal infections. Diarrhoea associated with infections resulting from oral-faecal contamination is the second leading cause of death in children under 5 years of age, primarily in Africa and South Asia. Currently there are no appropriate vaccines that could be easily administered on a global scale to prevent these infections. Synthetic biology has the potential to contribute to development of such vaccines. Our work is directed at developing a range of multivalent oral vaccines against the most common diarrhoea-causing bacteria, e.g., Escherichia coli, Shigella and Salmonella. If synthetic biology is to avoid the suspicion and possible revulsion of the public, scientists need to demonstrate that this new field has something real to offer.
Similar content being viewed by others
References
Annan KA (2000) http://www.un.org/millennium/sg/report/full.htm
Bailey C, Metcalf H, Crook B (2012) Synthetic biology: A review of the technology, and current and future needs from the regulatory framework in Great Britain. Health and Safety Executive, Research Report RR944. http://www.hse.gov.uk/research/rrpdf/rr944.pdf
Balmer A, Martin P (2008) Synthetic biology: social and ethical challenges institute for science and society, University of Nottingham. http://www.bbsrc.ac.uk/organisation/policies/reviews/scientific-areas/0806-synthetic-biology.aspx
Blakely GW, Murray NE (2009) DNA restriction and modification, in the encyclopedia of microbiology, 3rd Edition, edited by Moselio Schaechter, Elsevier
Bradbrook S (2007) HSE horizon scanning intelligence group short report synthetic biology. SR010. http://www.hse.gov.uk/horizons/
Burbelo PD, Ching KH, Han BL, Klimavicz CM, Iadarola MJ (2010) Synthetic biology for translational research. Am J Trans Res 2:381–389
Church G (2005) Let us go forth and safely multiply. Nature 438:423. doi:10.1038/438423a
Directive 2009/41/EC of the European Parliament and of the Council of 6 May 2009 on the contained use of genetically modified micro-organisms. Off J Eur Union. L 125/75. http://www.bmwf.gv.at/fileadmin/user_upload/forschung/gentechnik/2009-41-EC.pdf
European Commission (2010) Synthetic Biology: From Science to Governance. A workshop organised by the European Commission’s Directorate-General for Health and Consumers, Brussels. http://ec.europa.eu/health/…/docs/synbio_workshop_report_en.pdf
Fouchier R, Osterhaus A, Steinbruner J et al (2012) Preventing pandemics: the fight over flu. Nature 481:257–259. doi:10.1038/481257a
French CE, de Mora K, Joshi N, Elfick A, Haseloff J, Ajioka J (2011) Synthetic biology And the art of biosensor design. In: Institute of Medicine (US) Forum on Microbial Threats. The Science and Applications of Synthetic and Systems Biology: Workshop Summary. Washington (DC): National Academies Press (US). A5. http://www.ncbi.nlm.nih.gov/books/NBK84465/
Garfinkel MS, Endy D, Epstein GL, Friedman RM (2007) Synthetic genomics: options for governance available here. http://www.jcvi.org/cms/fileadmin/site/research/projects/synthetic-genomics-report/synthetic-genomics-report.pdf
Hoshino K et al (1999) Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J Immunol 162:3749–3752
ISBN: 978-92-4-159841-5 (NLM classification: WS 312) (WHO). http://whqlibdoc.who.int/publications/2009/9789241598415_eng.pdf
Kelle A (2007) Synthetic biology and biosecurity: awareness in Europe. Bradford Science and Technology Report No.9. http://www.synbiosafe.eu/uploads///pdf/Synbiosafe-Biosecurity_awareness_in_Europe_Kelle.pdf
Martin DK, Greenwood HL, Nisker J (2010) Public perceptions of ethical issues regarding adult predictive genetic testing. Health Care Anal 18:103–112
Maurer SM, Lucas KV, Terrell S (2006) From understanding to action: community-based options for improving safety and security in synthetic biology. Goldman School of Public Policy, University of California at Berkeley. http://gspp.berkeley.edu/iths/UC%20White%20Paper.pdf
Murray K, Bruce SA, Hinnen A, Wingfield P, van Erd PM, de Reus A, Schellekens H (1984) Hepatitis B virus antigens made in microbial cells immunise against viral infection. EMBO J 3:645–650
Pasotti L, Zucca S, Lupotto M, Cusella De Angelis MG, Magni P (2011) Characterization of a synthetic bacterial self-destruction device for programmed cell death and for recombinant proteins release. J Biol Eng 5
Presidential Commission for the Study of Bioethical Issues (2010). New directions: the ethics of synthetic biology and emerging technologies. http://bioethics.gov/cms/sites/default/files/PCSBI-Synthetic-Biology-Report-12.16.10_0.pdf
WHO report (2011) The world health report—Health systems financing: the path to universal coverage. http://www.who.int/whr/2010/en/index.html
Ro D, Paradise EM, Ouellet M, Fisher KJ, Newman KL, Ndungu JM, Ho KA, Eachus RA, Ham TS, Kirby J, Chang MCY, Withers ST, Shiba Y, Sarpong R, Keasling JD (2006) Production of the antimalarial drug precursor artemisinic acid in engineered yeast. Nature 440:940–943
Ruder WC, Lu T, Collins JJ (2011) Synthetic biology moving into the clinic. Science 333:1248–1252
Schmidt M, Ganguli-Mitra A, Torgersen H, Kelle A, Deplanes A, Biller-Andorno N (2009) A priority paper for the societal and ethical aspects of synthetic biology. Syst Synth Biol 3:3–7
Technology Strategy Board on behalf of UK Synthetic Biology Roadmap Coordination Group (2012). A synthetic biology roadmap for the UK. http://www.rcuk.ac.uk/Publications/reports/Pages/syntheticbiologyroadmap.aspx
van Est R, de Vriend H, Walhout B (2007) Constructing Life: The World of Synthetic Biology, Rathenau Institute—Technology Assessment. http://www.synbiosafe.eu/uploads///pdf/BAP_Synthetic_biology_nov2007[1].pdf
Veenstra DL, Roth JA, Garrison LP Jr, Ramsey SD, Burke W (2010) A formal risk-benefit framework for genomic tests: facilitating the appropriate translation of genomics into clinical practice. Genetics in Medicine 12:686–693. doi:10.1097/GIM.0b013e3181eff533
Weber W, Schoenmakers R, Keller B, Gitzinger M, Grau T, Daoud-El Baba M, Sander P, Fussenegger M (2008) A synthetic mammalian gene circuit reveals antituberculosis compounds. PNAS 105:9994–9998
WHO (2009) Diarrhoea: Why children are still dying and what can be done
Windbichler N, Menichelli M, Papathanos PA, Thyme SB, Li H, Ulge UY, Hovde BT, Baker D, Monnat RJ Jr, Burt A, Crisanti A (2011) A synthetic homing endonuclease-based gene drive system in the human malaria mosquito. Nature 473:212–217
Acknowledgments
We are grateful to Conor Douglas and Dirk Stemerding for organizing the SYBHEL workshop on Synthetic Biology and Global Health. PV is supported by a Bill and Melinda Gates Foundation Grant awarded to GWB.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Vohra, P., Blakely, G.W. Easing the global burden of diarrhoeal disease: can synthetic biology help?. Syst Synth Biol 7, 73–78 (2013). https://doi.org/10.1007/s11693-013-9114-6
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11693-013-9114-6